Updated Jul 16, 2026
Goin Kathleen has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.77M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 25 | $112.23 | $3K |
| 2026-06-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 1.9K | $111.31 | $210K |
| 2026-06-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 2.4K | $110.26 | $264K |
| 2026-06-22 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.1K | $9.08 | $20K |
| 2026-06-22 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.2K | $7.14 | $15K |
| 2026-05-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 48 | $111.89 | $5K |
| 2026-05-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 891 | $111.30 | $99K |
| 2026-05-22 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 3.4K | $110.35 | $371K |
| 2026-05-22 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.1K | $9.08 | $20K |
| 2026-05-22 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.2K | $7.14 | $15K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 100 | $130.33 | $13K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 639 | $129.17 | $83K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 561 | $128.23 | $72K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 1.5K | $127.13 | $191K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale | 1.5K | $125.96 | $189K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.1K | $9.08 | $20K |
| 2026-04-17 | PVLA | PALVELLA THERAPEUTICS, INC. | M — Option exercise | 2.2K | $7.14 | $15K |
| 2026-03-20 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 304 | $119.08 | $36K |
| 2026-03-20 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 1.7K | $118.37 | $205K |
| 2026-03-20 | PVLA | PALVELLA THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 2.3K | $117.56 | $267K |
Goin Kathleen is a corporate insider — currently tracked as Chief Operating Officer of PALVELLA THERAPEUTICS, INC. (PVLA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 18 open-market sales ($2.77M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goin Kathleen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.